# Hyundai Bioscience Co., Ltd. – FDA Inspection, Jun 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/hyundai-bioscience-co-ltd/e3e7ef31-d869-40e4-905d-81f59ad0726b
Source feed: FDA_Inspections

> FDA inspection 1056839 of Hyundai Bioscience Co., Ltd., June 22, 2018. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056839
- Company Name: Hyundai Bioscience Co., Ltd.
- Inspection Date: 2018-06-22
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 9

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)

Company: https://www.keypedia.com/companies/hyundai-bioscience-co-ltd/f31608d5-a690-4423-850f-2975e1339e1f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c